Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04195555Phase 2Active Not Recruiting
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
Recurrent EpendymomaRecurrent Ewing SarcomaRecurrent Hepatoblastoma+30 more
PrincipalinvestigatorStart date: 2020-07-20

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Giselle Sholler, MD

Beat Childhood Cancer at Atrium Health

Related
10 trials

Shared therapeutic areas:

Refractory NeuroblastomaWilms Tumor
Similarity Score2%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Recurrent Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Edward A Neuwelt

OHSU Knight Cancer Institute

Related
6 trials

Shared therapeutic areas:

Recurrent Malignant Germ Cell TumorRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Behnam Badie

City of Hope Medical Center

Related
6 trials

Shared therapeutic areas:

Recurrent Malignant GliomaRefractory Malignant Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Patricia M LoRusso

Yale University Cancer Center LAO

Related
6 trials

Shared therapeutic areas:

Refractory Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Amir A Jazaeri

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Recurrent OsteosarcomaRefractory Osteosarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Luhua (Michael) Wang

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Recurrent Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

AeRang Kim, MD, PhD

Children's National Research Institute

Related
7 trials

Shared therapeutic areas:

Wilms Tumor
Similarity Score1%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Wilms Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Maryam Fouladi

Children's Oncology Group

Related
5 trials

Shared therapeutic areas:

Recurrent Neuroblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04195555Phase 2PrincipalInvestigator

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Recurrent EpendymomaRecurrent Ewing SarcomaRecurrent Hepatoblastoma+30 more
Active Not Recruiting

All 1 trials loaded